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largely unknown. Given the existence
of Bartonella spp. in every mammal
group examined to date, the diversity
of the genus is probably much greater
than has been observed among the
strains examined to date. In Greece,
serologic evidence of human infection
with B. henselae and B. quintana (8),
has been found and a case of B. quin-
tana endocarditis has been established
(unpub. data). The public health rele-
vance of Bartonella infections in
small mammals in Greece compared
with other countries remains to be
defined.
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Reemerging Murine
Typhus, Japan
To the Editor: Murine typhus is
an arthropod-borne infectious disease
caused by Rickettsia typhi, which is
distributed widely around the world
(1–4). In Japan, tsutsugamushi dis-
ease occurs most frequently in per-
sons infected with rickettsioses (5).
Spotted fever caused by R. japonica
also occurs in the southwestern part of
Japan (6,7). In the 1940s and 1950s,
many murine typhus cases were
reported in Japan. These diagnoses
were made according to the clinical
features of the illness and the reactiv-
ity of the serum samples to OX19 in
Weil-Felix tests. A few cases were
diagnosed on the basis of symptoms
exhibited by animals infected with
isolated rickettsiae and complement
fixation tests, in addition to results of
the Weil-Felix tests. The Weil-Felix
test is useful for preliminary screen-
ing of rickettsiosis; however, the reac-
tion could indicate epidemic typhus or
spotted fever in some cases. Since
1958, only three murine typhus cases
have been reported in Japan (8). In
these cases, no serologic tests for epi-
demic typhus were conducted. Serum
sample from patients with epidemic
typhus and murine typhus frequently
possess serologic cross-reactivity to
R. typhi and R. prowazekii, respective-
ly (9). Thus, the possibility of epidem-
ic typhus could not be excluded defin-
itively in these cases. 
On May 4, 2003, a 56-year-old
man living in Tokushima, Japan,
sought medical care; he had a temper-
ature of 39.1°C and exanthema on the
trunk and the upper limbs. No surface
lymph nodes were palpable. He was
treated with lincomycin and cefdi-
toren pivoxil with no improvement.
On day 3, the patient informed care-
givers that he had been in a bamboo
grove on days 1 and 11 before the
onset of symptoms. C-reactive protein
of the serum sample collected on day
3 was positive (= 7.6 mg/dL). From
this finding, spotted fever was sus-
pected; the disease is endemic in
Tokushima. On day 4, the exanthema
had spread systemically, and treat-
ment with minocycline was started,
which led to a gradual decrease in
fever and rashes. The patient was
admitted to the Tokushima University
Hospital on day 6 of the illness for
diagnosis and further treatment. 
Serum samples were collected
from the patient on days 5, 6, 9, 20,
and 34. Indirect immunoperoxidase
tests on the serum samples for tsut-
sugamushi disease, spotted fever,
murine typhus, and Q fever on day 5
of the illness were negative for
immunoglobulin (Ig) G and IgM anti-
bodies (<1:40). Weil-Felix tests on the
serum samples on days 5 and 9 of the
illness were negative for OX2, OX19,
and OXK. Indirect immunofluores-
cence of the serum samples on days 6,
9, 20, and 34 of the illness was con-
ducted by using strains 18 and
Wilmington of R. typhi, and the strain
Breinl of R. prowazekii as typhus
group rickettsiae; and the strain YH of
R. japonica, the strain Malish 7 of R.
conorii, and the strain Tick of R. mon-
tanensis as the spotted fever group
rickettsiae. All serum samples tested
for the rickettsiae showed an IgM titer
of 1:20. On the other hand, the IgM
titers of these serum samples, to the
Orientia tsutsugamushi were <1:20.
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For the IgG antibodies of these serum,
spotted fever group rickettsiae were
negative (<1:20). However, the
typhus group rickettsiae were positive
for IgG antibodies. Among the typhus
group rickettsiae, strain 18 of R. typhi
had the highest elevated titers. The
titers to the sera on days 6, 9, 20, and
34 of illness were 1:80, 1:160, 1:160,
and 1:80, respectively. Another strain
of R. typhi, the strain Wilmington, had
lower titers of 1:40, 1:80, 1:80, and
1:40, on days 6, 9, 20, and 34 of the
illness, respectively. This could have
occurred because strain 18 may be a
closer antigenic relation of the
causative agent than is the strain
Wilmington. R. prowazekii demon-
strated the lowest IgG titers among
typhus group rickettsiae for these
serum samples, <1:20, 1:20, 1:40, and
1:20, on days 6, 9, 20, and 34 of the
illness, respectively. These results
suggested that the disease was murine
typhus. 
To demonstrate more detailed anti-
genic reactivity, Western immuno-
blotting of rickettsiae was conducted
by using a serum specimen from day
20. All of the rickettsiae were reactive
to the serum to various extents. The
serum reacted to the ladder-like
lipopolysaccharide of R. typhi and R.
prowazekii; the antigenicity of rick-
ettsial lipopolysaccharide is group-
specific. As expected from the
immunofluorescence data, no reaction
was demonstrated to the lipopolysac-
charide of spotted fever group rick-
ettsiae, R. japonica and R. montanen-
sis, although trace cross-reactivity,
mainly to rOmpB, was shown. Thus,
typhus group rickettsiosis was sus-
pected for this case on the basis of
these data. Compared to the trace
reaction of spotted fever group rick-
ettsiae to rOmpB, a stronger, but still
weak, reaction was detected to the
heat-labile state of rOmpB of R.
prowazekii, and an extremely strong
reaction was demonstrated to the
heat-labile and heat-stable states of
rOmpB of R. typhi. These results
strongly suggested that the disease
was murine typhus.
To confirm this diagnosis, we con-
ducted absorption tests as described
previously (10). The patient serum
collected on day 20 showed complete
absorption by the homologous anti-
gen, the purified R. typhi strain 18,
demonstrating no reaction to R. typhi
or to R. prowazekii by immunofluo-
rescence. However, the serum showed
incomplete absorption by the heterol-
ogous antigen, the purified R.
prowazekii, demonstrating no reactiv-
ity to R. prowazekii but some reactiv-
ity to R. typhi. These tests confirmed
the diagnosis of murine typhus.
Murine typhus has never been
reported in Japan after the 1950s,
except for the three suspected cases
and this case. Although other undiag-
nosed cases may have occurred, they
appear to be few; many febrile cases
of exanthema have been examined for
various rickettsioses, especially after
spotted fever was diagnosed in Japan
in 1984. Murine typhus may have
reemerged because of the recent
increase of black rats, Rattus rattus, in
Japan. This patient mentioned that he
had captured a rat and disposed of the
carcass about a week before the onset
of symptoms. Infection could have
resulted at that time from contamina-
tion with feces of infected fleas such
as the oriental rat flea, Xenopsylla
cheopis. Historical review indicates
that this is the first complete serolog-
ic diagnosis of a murine typhus case
in Japan.
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